APA (7th ed.) Citation

Port, A., Shaw, J. V., Klopp-Schulze, L., Bytyqi, A., Vetter, C., Hussey, E., . . . Goteti, K. (2021). Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8. Pharmacology Research & Perspectives, 9(5), 1. https://doi.org/10.1002/prp2.842

Chicago Style (17th ed.) Citation

Port, Andreas, et al. "Phase 1 Study in Healthy Participants of the Safety, Pharmacokinetics, and Pharmacodynamics of Enpatoran (M5049), a Dual Antagonist of Toll-like Receptors 7 and 8." Pharmacology Research & Perspectives 9, no. 5 (2021): 1. https://doi.org/10.1002/prp2.842.

MLA (9th ed.) Citation

Port, Andreas, et al. "Phase 1 Study in Healthy Participants of the Safety, Pharmacokinetics, and Pharmacodynamics of Enpatoran (M5049), a Dual Antagonist of Toll-like Receptors 7 and 8." Pharmacology Research & Perspectives, vol. 9, no. 5, 2021, p. 1, https://doi.org/10.1002/prp2.842.